Public Policy Agenda

Mission 

The American Society for Parenteral and Enteral Nutrition (ASPEN) seeks an environment in which every patient receives safe, efficacious, and high quality care by advancing the science and practice of clinical nutrition and metabolism.

Program Objectives

ASPEN’s intent includes active advocacy for high priority issues pertaining to nutrition support, including working in coalition with other like-minded organizations, as appropriate. Our advocacy also includes working with Congress, the Executive branch (NIH, regulatory agencies, CMS), public/private groups, and the courts (amicus briefs) to:

  • Advocate for optimal nutrition as a national patient safety issue and optimal nutrition as a national goal 
  • Work on patient access to nutrition care through changing reimbursement 
  • Improve nutrition support therapy by advocating for new needed products and product shortages solutions
  • Improve the safety and quality of care for all patients/consumers receiving nutrition support therapy, resulting in improved patient outcomes 
  • Advocate for reimbursement to ensure that beneficiaries of government funded health programs receive the highest quality nutrition support care 
  • Sponsor the concept of a fair marketplace (pricing) that does not jeopardize the provision of safe and quality nutrition support. Guarantee accessibility to products and care service, monitor and act on pricing to assure adequate reimbursement to providers for products, equipment, supplies, and care services to assure patient accessibility to therapy
  • Promote continued federal funding for nutrition and metabolic research, education, and training 
  • Advocate for reform that benefits the efficacious delivery of nutrition support
  • Promote an interdisciplinary approach to public policy for the nutrition care of patients
  • Adequate funding support for nutrition clinician services to improve patient care

Priority Issues

  1. Address regulations in order to: 
    1. Advance information technology and safe practice issues related to parenteral and enteral nutrition (for example: compounding pharmacy oversight, drug shortages, PN safety, connectors for enteral devices) 
    2. Monitor and influence development of new definitions for medical foods and billing codes, such as with malnutrition, nutrition therapy, and metabolic support 
    3. Integrate, coordinate, and develop initiatives to better define, diagnose, and treat disease related malnutrition 
    4. Promote adequate coverage and reimbursement for parenteral and enteral nutrition therapy
        
  2. Work to improve funding for the support of: 
    1. Healthcare professional education and training in nutrition 
    2. Nutrition support therapy related research 
     

Approved by the ASPEN Board of Directors April 19, 2017